false
Catalog
Live Webinar - Charcot Neuroarthropathy: Complicat ...
Program and CME Materials
Program and CME Materials
Back to course
Pdf Summary
The content provided is an agenda for a webinar titled "Foot & Ankle Focus: Charcot Neuroarthropathy: Complications of Surgical Management," which took place on June 24, 2021. The webinar was organized by the American Orthopaedic Foot & Ankle Society (AOFAS) with the aim of improving orthopaedic foot and ankle care. The webinar focused on discussing the surgical management of Charcot neuroarthropathy, including complications that may arise during the surgical process, how to avoid these complications, and how to manage them when they occur. The faculty members involved in the webinar included Dr. Jesse F. Doty, Dr. Richard T. Laughlin, Dr. Selene G. Parekh, and Dr. Philip B. Kaiser, who shared their experiences and insights on the topic. The webinar was free for AOFAS members and orthopaedic residents/fellows, and it was supported by grants from Arthrex Inc. and Stryker. The webinar provided attendees with a maximum of 1 AMA PRA Category 1 Credit™. The agenda also includes disclosures from the faculty members and planners regarding any financial relationships or affiliations with commercial interests. The AOFAS ensures that all educational activities are balanced and free of commercial bias. The provided content also includes the background and mission statement of the AOFAS, the target audience for the webinar, and the program's accreditation and credit designation statements.
Keywords
Foot & Ankle Focus
Charcot Neuroarthropathy
Complications of Surgical Management
American Orthopaedic Foot & Ankle Society
Orthopaedic Foot and Ankle Care
Surgical Management
Avoiding Complications
Managing Complications
Faculty Members
AMA PRA Category 1 Credit™
American Orthopaedic Foot & Ankle Society
®
Orthopaedic Foot & Ankle Foundation
9400 W. Higgins Road, Suite 220, Rosemont, IL 60018
800-235-4855 or +1-847-698-4654 (outside US)
Copyright
©
2021 All Rights Reserved
Privacy Statement & Legal Disclosures
×
Please select your language
1
English